Yaara Porat Preclinical Research Department Novocure Ltd., Haifa, Israel Biography Publications Institution JoVE Articles Yaara Porat has not added a biography. If you are Yaara Porat and would like to personalize this page please email our Author Liaison for assistance. Publications Alternating Electric Fields (TTFields) in Combination with Paclitaxel Are Therapeutically Effective Against Ovarian Cancer Cells in Vitro and in Vivo International Journal of Cancer. Dec, 2016 | Pubmed ID: 27561100 Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells Scientific Reports. Dec, 2015 | Pubmed ID: 26658786 Alternating Electric Fields (tumor-treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-small Cell Lung Cancer Both in Vitro and in Vivo Seminars in Oncology. Oct, 2014 | Pubmed ID: 25213867 Mitotic Disruption and Reduced Clonogenicity of Pancreatic Cancer Cells in Vitro and in Vivo by Tumor Treating Fields Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]. Jan-Feb, 2014 | Pubmed ID: 24555979 Microbial Growth Inhibition by Alternating Electric Fields in Mice with Pseudomonas Aeruginosa Lung Infection Antimicrobial Agents and Chemotherapy. Aug, 2010 | Pubmed ID: 20547811 Microbial Growth Inhibition by Alternating Electric Fields Antimicrobial Agents and Chemotherapy. Oct, 2008 | Pubmed ID: 18663026 Structure-activity Relationships of Antibacterial Acyl-lysine Oligomers Chemistry & Biology. Apr, 2008 | Pubmed ID: 18420142 קביעת תדירות המעכבות האופטימלית עבור תאים סרטניים באמצעות גידול טיפול פילדס (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
קביעת תדירות המעכבות האופטימלית עבור תאים סרטניים באמצעות גידול טיפול פילדס (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
